Search results for: Health Policy and Regulation
Filter search results
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
…policy, HTA, and procurement. Share this: Download publication Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to…
Around The World in HTAs: The Slovak Republic – Valuing the Future
13 September 2023
…working groups, NIHO, and the Section of Pharmacy and Drug Policy. Expert working groups provide clinical assessments, NIHO provides technology assessments, and The Section of Pharmacy and Drug Policy issues…
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…and medicine research and development (R&D) is significantly lower in comparison to other diseases such as cancer. However, recent breakthroughs and growing R&D pipeline show that this area has high…
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…and budget impact analyses: second edition. Published online 2012. https://www.kce.fgov.be/en/publications/all-reports/belgian-guidelines-for-economic-evaluations-and-budget-impact-analyses-second-edition Zorginstituut Nederland (ZIN). Guideline for economic evaluations in healthcare. Published online 2016. Accessed October 24, 2022. https://english.zorginstituutnederland.nl/publications/reports/2016/06/16/guideline-for-economic-evaluations-in-healthcare Agencja Oceny Technologii…
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
…for regulation. Table 1 gives an overview of utility regulation. There has been a widespread assumption that profit control based on ‘cost-plus’ regulation is less effective in getting value-for-money for…
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…to hear calls for more joined-up thinking and early and meaningful stakeholder dialogue and collaboration. It is also important to remain reflective and ensure policy levers are joined-up and not…
Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB
24 March 2022
…on Health. Available from https://www.ohe.org/publications/tuberculosis. Kettler, H. and Towse, A. (2002) Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty. OHE Monograph. Available from https://www.ohe.org/publications/public-private-partnerships-research-and-development-medicines-and-vaccines-diseases…
Risk Adjusting Health Care Resource Allocations
1 December 1999
Most health care systems are characterised by both purchasers (insurers, health authorities), who buy health care for a particular population, and providers (hospitals, primary care physicians), who supply health care…
The Digitalisation of Health Care During COVID-19: Consideration of the Long-Term Consequences
28 April 2020
…and patients. While the trend towards digitalisation of health care allows for potential improvements in access, its impact on health outcomes and health inequalities must be carefully considered to ensure…